Statin Use is Associated With Reduced Risk of Histologic Subtypes of Esophageal Cancer:a Nested Case-Control Analysis
Tools
Alexandre, Leo, Clark, Allan B, Bhutta, Hina Y, Holt, Sean, Lewis, Michael Pn and Hart, Andrew R (2014) Statin Use is Associated With Reduced Risk of Histologic Subtypes of Esophageal Cancer:a Nested Case-Control Analysis. Gastroenterology, 146 (3). 661–668. ISSN 0016-5085
![]() |
Microsoft Word (acceptance e-mail)
- Submitted Version
Download (16kB) |
Abstract
Most patients with esophageal adenocarcinoma (EAC) or squamous cell cancer (ESCC) present with advanced, incurable disease. Statins have reported anti-carcinogenic effects and may be chemoprotective. We investigated the association between regular use of statins and the main histologic subtypes of esophageal malignancy (EAC, esophagogastric junctional adenocarcinoma [EGJA], and ESCC) in the UK general population.
Item Type: | Article |
---|---|
Additional Information: | Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved. |
Uncontrolled Keywords: | esophageal cancer,statins,aetiology |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
Depositing User: | Pure Connector |
Date Deposited: | 20 Jan 2014 15:54 |
Last Modified: | 05 Feb 2021 00:52 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/46092 |
DOI: | 10.1053/j.gastro.2013.11.046 |
Actions (login required)
![]() |
View Item |